| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_431309bc8dab94a0ee0e2aa5aeacd48d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fadd236fed63ed05064b8817aecfcb42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa9d8a66ecec194c5d4e9c4b9884ed7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_299d45c0cfff501865f07d7a2d3ca5cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ce84dda5d33878ae0e91e9f57b1f561 |
| publicationDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011224032-B2 |
| titleOfInvention |
Aglycosyl Anti-CD154 (CD40 Ligand) Antibodies and Uses Thereof |
| abstract |
The invention relates to aglycosyl anti-CD154 antibodies or antibody derivatives, characterized by a modification at the conserved N-linked site in the CH2 domains of the Fc portion of said antibody. The invention also relates to the treatment of immune response related diseases and inhibition of unwanted immune responses with such aglycosylated anti-CD 154 antibodies or antibody derivatives thereof. |
| priorityDate |
2003-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |